Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $243.82 | 5 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $152.42 | 1 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $55.60 | 2 | $0 (2023) |
| ANI Pharmaceuticals, Inc. | $19.13 | 1 | $0 (2024) |
| Mylan Specialty L.P. | $16.67 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $188.22 | 3 | Medtronic, Inc. ($152.42) |
| 2023 | $28.73 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($28.73) |
| 2022 | $26.87 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($26.87) |
All Payment Transactions
5 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/10/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 09/03/2024 | Medtronic, Inc. | MICRA (Device) | Food and Beverage | In-kind items and services | $152.42 | General |
| Category: Pacemakers | ||||||
| 03/27/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 01/19/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT, SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $28.73 | General |
| Category: RESPIRATORY | ||||||
| 11/03/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT, SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $26.87 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 818 | 1,386 | $378,781 | $170,561 |
| 2022 | 3 | 213 | 452 | $129,962 | $59,641 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 252 | 449 | $194,866 | $78,718 | 40.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 288 | 639 | $102,879 | $63,425 | 61.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 109 | 114 | $35,568 | $15,126 | 42.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 54 | 54 | $25,943 | $4,658 | 18.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 36 | 51 | $5,771 | $3,881 | 67.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 28 | 28 | $3,112 | $1,845 | 59.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 13 | 13 | $2,223 | $1,436 | 64.6% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2023 | 18 | 18 | $7,218 | $1,240 | 17.2% |
| 76937 | Ultrasonic guidance for blood vessel access | Facility | 2023 | 20 | 20 | $1,200 | $232.40 | 19.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 88 | 194 | $84,196 | $35,236 | 41.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 98 | 230 | $37,030 | $19,755 | 53.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 27 | 28 | $8,736 | $4,650 | 53.2% |
About Bert Liu
Bert Liu is a Pulmonary Disease healthcare provider based in Pasadena, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/25/2016. The National Provider Identifier (NPI) number assigned to this provider is 1437511607.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Bert Liu has received a total of $243.82 in payments from pharmaceutical and medical device companies, with $188.22 received in 2024. These payments were reported across 5 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($243.82).
As a Medicare-enrolled provider, Liu has provided services to 1,031 Medicare beneficiaries, totaling 1,838 services with total Medicare billing of $230,202. Data is available for 2 years (2022–2023), covering 12 distinct procedure/service records.
Practice Information
- Specialty Pulmonary Disease
- Location Pasadena, CA
- Active Since 03/25/2016
- Last Updated 10/17/2022
- Taxonomy Code 207RP1001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1437511607
Products in Payments
- MICRA (Device) $152.42
- STIOLTO RESPIMAT (Drug) $55.60
- PURIFIED CORTROPHIN GEL (Drug) $19.13
- YUPELRI (Drug) $16.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Pasadena
Rajkumar Dasgupta, M.d, M.D
Pulmonary Disease — Payments: $916,165
Dr. Donald Kroe, M.d, M.D
Pulmonary Disease — Payments: $9,010
Ashish Patel, Md, MD
Pulmonary Disease — Payments: $8,866
Dr. Michael Gurevitch, M.d, M.D
Pulmonary Disease — Payments: $8,728
Pang-Chieh Eu, M.d, M.D
Pulmonary Disease — Payments: $1,732
Magdalena Arenas, Md, MD
Pulmonary Disease — Payments: $1,199